Co-Diagnostics Inc
NASDAQ:CODX

Watchlist Manager
Co-Diagnostics Inc Logo
Co-Diagnostics Inc
NASDAQ:CODX
Watchlist
Price: 1.22 USD 0.83% Market Closed
Market Cap: 38.9m USD
Have any thoughts about
Co-Diagnostics Inc?
Write Note

Intrinsic Value

CODX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CODX stock under the Base Case scenario is 0.42 USD. Compared to the current market price of 1.22 USD, Co-Diagnostics Inc is Overvalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CODX Intrinsic Value
0.42 USD
Overvaluation 65%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Co-Diagnostics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CODX cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CODX?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Co-Diagnostics Inc

Provide an overview of the primary business activities
of Co-Diagnostics Inc.

What unique competitive advantages
does Co-Diagnostics Inc hold over its rivals?

What risks and challenges
does Co-Diagnostics Inc face in the near future?

Has there been any significant insider trading activity
in Co-Diagnostics Inc recently?

Summarize the latest earnings call
of Co-Diagnostics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Co-Diagnostics Inc.

Provide P/S
for Co-Diagnostics Inc.

Provide P/E
for Co-Diagnostics Inc.

Provide P/OCF
for Co-Diagnostics Inc.

Provide P/FCFE
for Co-Diagnostics Inc.

Provide P/B
for Co-Diagnostics Inc.

Provide EV/S
for Co-Diagnostics Inc.

Provide EV/GP
for Co-Diagnostics Inc.

Provide EV/EBITDA
for Co-Diagnostics Inc.

Provide EV/EBIT
for Co-Diagnostics Inc.

Provide EV/OCF
for Co-Diagnostics Inc.

Provide EV/FCFF
for Co-Diagnostics Inc.

Provide EV/IC
for Co-Diagnostics Inc.

Show me price targets
for Co-Diagnostics Inc made by professional analysts.

What are the Revenue projections
for Co-Diagnostics Inc?

How accurate were the past Revenue estimates
for Co-Diagnostics Inc?

What are the Net Income projections
for Co-Diagnostics Inc?

How accurate were the past Net Income estimates
for Co-Diagnostics Inc?

What are the EPS projections
for Co-Diagnostics Inc?

How accurate were the past EPS estimates
for Co-Diagnostics Inc?

What are the EBIT projections
for Co-Diagnostics Inc?

How accurate were the past EBIT estimates
for Co-Diagnostics Inc?

Compare the revenue forecasts
for Co-Diagnostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Co-Diagnostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Co-Diagnostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Co-Diagnostics Inc compared to its peers.

Compare the P/E ratios
of Co-Diagnostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Co-Diagnostics Inc with its peers.

Analyze the financial leverage
of Co-Diagnostics Inc compared to its main competitors.

Show all profitability ratios
for Co-Diagnostics Inc.

Provide ROE
for Co-Diagnostics Inc.

Provide ROA
for Co-Diagnostics Inc.

Provide ROIC
for Co-Diagnostics Inc.

Provide ROCE
for Co-Diagnostics Inc.

Provide Gross Margin
for Co-Diagnostics Inc.

Provide Operating Margin
for Co-Diagnostics Inc.

Provide Net Margin
for Co-Diagnostics Inc.

Provide FCF Margin
for Co-Diagnostics Inc.

Show all solvency ratios
for Co-Diagnostics Inc.

Provide D/E Ratio
for Co-Diagnostics Inc.

Provide D/A Ratio
for Co-Diagnostics Inc.

Provide Interest Coverage Ratio
for Co-Diagnostics Inc.

Provide Altman Z-Score Ratio
for Co-Diagnostics Inc.

Provide Quick Ratio
for Co-Diagnostics Inc.

Provide Current Ratio
for Co-Diagnostics Inc.

Provide Cash Ratio
for Co-Diagnostics Inc.

What is the historical Revenue growth
over the last 5 years for Co-Diagnostics Inc?

What is the historical Net Income growth
over the last 5 years for Co-Diagnostics Inc?

What is the current Free Cash Flow
of Co-Diagnostics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Co-Diagnostics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Co-Diagnostics Inc

Current Assets 48.2m
Cash & Short-Term Investments 44.9m
Receivables 551.5k
Other Current Assets 2.8m
Non-Current Assets 32.5m
Long-Term Investments 627.9k
PP&E 5.6m
Intangibles 26.3m
Other Non-Current Assets 10
Current Liabilities 5.3m
Accounts Payable 1.9m
Accrued Liabilities 2.4m
Other Current Liabilities 1.1m
Non-Current Liabilities 3m
Other Non-Current Liabilities 3m
Efficiency

Earnings Waterfall
Co-Diagnostics Inc

Revenue
9.1m USD
Cost of Revenue
-3.7m USD
Gross Profit
5.5m USD
Operating Expenses
-44.2m USD
Operating Income
-38.7m USD
Other Expenses
1.1m USD
Net Income
-37.6m USD

Free Cash Flow Analysis
Co-Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q2 2024, Co-Diagnostics achieved a remarkable revenue increase to $2.7 million, up from $0.2 million year-over-year, primarily driven by $2.5 million in grant revenue. Despite a net loss of $7.6 million, reduced operating expenses reflect better cost management. The firm is progressing towards a commercial launch of its Co-Dx PCR platform, having submitted a pivotal 510(k) application to the FDA. The market for tuberculosis testing is projected to reach over $3.6 billion in four years, positioning Co-Diagnostics for significant growth as it targets both domestic and international markets.

What is Earnings Call?
Fundamental Scores

CODX Profitability Score
Profitability Due Diligence

Co-Diagnostics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 1-Year Revenue Growth
Positive 3-Year Average ROIC
Declining ROE
27/100
Profitability
Score

Co-Diagnostics Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

CODX Solvency Score
Solvency Due Diligence

Co-Diagnostics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
65/100
Solvency
Score

Co-Diagnostics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CODX Price Targets Summary
Co-Diagnostics Inc

Wall Street analysts forecast CODX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CODX is 1.53 USD with a low forecast of 1.52 USD and a high forecast of 1.58 USD.

Lowest
Price Target
1.52 USD
24% Upside
Average
Price Target
1.53 USD
25% Upside
Highest
Price Target
1.58 USD
29% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CODX?

Click here to dive deeper.

Dividends

Co-Diagnostics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CODX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CODX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

CODX News

Other Videos

Profile

Co-Diagnostics Inc Logo
Co-Diagnostics Inc

Country

United States of America

Industry

Health Care

Market Cap

38.9m USD

Dividend Yield

0%

Description

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 101 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

Contact

UTAH
Salt Lake City
4049 S Highland Dr
+18012789769.0
codiagnostics.com

IPO

2017-07-12

Employees

101

Officers

Chairman & CEO
Mr. Dwight H. Egan
CFO & Company Secretary
Mr. Brian L. Brown CPA
President
Mr. Richard David Abbott
Co-Founder & Member of Scientific Advisory Board
Dr. Brent C. Satterfield Ph.D.
Chief Operating Officer
Mr. David Nielsen
Vice President of Finance & Accounting
Mr. Dan Bohrer CPA
Show More
Chief Technology Officer
Mr. Christopher Thurston
Head of Investor Relations
Mr. Andrew Benson
Senior Vice President of Overseas Operations & Strategic Alliances
Dr. Mayuranki Almaula
Head of Commercialization LATAM/EUR
Mr. Cameron Gundry
Show Less

See Also

Discover More
What is the Intrinsic Value of one CODX stock?

The intrinsic value of one CODX stock under the Base Case scenario is 0.42 USD.

Is CODX stock undervalued or overvalued?

Compared to the current market price of 1.22 USD, Co-Diagnostics Inc is Overvalued by 65%.

Back to Top